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Classic neuroenergetic research has emphasized the role of glucose, its transport and
its metabolism in sustaining normal neural function leading to the textbook statement
that it is the necessary and sole metabolic fuel of the mammalian brain. New evidence,
including the Astrocyte-to-Neuron Lactate Shuttle hypothesis, suggests that the brain
can use other metabolic substrates. To further study that possibility, we examined
the effect of intraperitoneally administered metabolic fuels (glucose, fructose, lactate,
pyruvate, ß-hydroxybutyrate, and galactose), and insulin, on blood, and extracellular
brain levels of glucose and lactate in the adult male CD1 mouse. Primary motor cortex
extracellular levels of glucose and lactate were monitored in freely moving mice with
the use of electrochemical electrodes. Blood concentration of these same metabolites
were obtained by tail vein sampling and measured with glucose and lactate meters.
Blood and extracellular fluctuations of glucose and lactate were monitored for a 2-h
period. We found that the systemic injections of glucose, fructose, lactate, pyruvate,
and ß-hydroxybutyrate increased blood lactate levels. Apart for a small transitory rise
in brain extracellular lactate levels, the main effect of the systemic injection of glucose,
fructose, lactate, pyruvate, and ß-hydroxybutyrate was an increase in brain extracellular
glucose levels. Systemic galactose injections produced a small rise in blood glucose and
lactate but almost no change in brain extracellular lactate and glucose. Systemic insulin
injections led to a decrease in blood glucose and a small rise in blood lactate; however
brain extracellular glucose and lactate monotonically decreased at the same rate. Our
results support the concept that the brain is able to use alternative fuels and the current
experiments suggest some of the mechanisms involved.
Keywords: brain metabolism, blood-brain barrier, galactose, insulin, pyruvate, beta-hydroxybutyrate, fructose,
astrocytes
INTRODUCTION
The study of mammalian brain bioenergetics has centered on the transport of glucose and its
metabolism in the presence of oxygen. This view is based on the inescapable fact that the brain
eventually ceases to function in the complete absence of either glucose or oxygen. The various
aspects of the brain’s metabolism of glucose have been extensively studied and form the basis of
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our understanding regarding how the brain uses energy. The
possibility that the brain could use different metabolic substrates
or that intermediary metabolic substrates could play a major
role in brain metabolism has been suggested at various times
in the history of brain metabolism research (Schurr, 2014). The
revival of some earlier hypotheses have crystalized around the
astrocyte-lactate shuttle hypothesis. Modeled from the lactate
shuttle in muscles (Brooks, 1986, 2000; Brooks et al., 1999;
Giugliano et al., 2008), the Astrocyte-to-Neuron Lactate Shuttle
(ANLS) hypothesis was first proposed by Pellerin and Magistretti
(1994). This hypothesis postulates that in times of increased
neuronal activity, and thus energy demand, astrocytes take up
blood glucose via their particularly well-positioned endfeet on
capillaries and convert this glucose to lactate. Lactate is then
shuttled to surrounding neurons for oxidative phosphorylation,
avoiding the glycolytic steps involved in the full metabolism of
glucose.
Support for the ANLS hypothesis comes from a variety
of research fields. Some key findings center on molecular
studies that have identified a mitochondrial redox complex
comprised of a monocarboxylate transporter (MCT1) and lactate
dehydrogenase (LDH) enzyme in neurons (Brooks et al., 1999;
Hashimoto and Brooks, 2008; Hashimoto et al., 2008; Passarella
et al., 2008). Consequently, neuronal mitochondria would appear
to possess the ability to take in lactate and convert it to
pyruvate in order to sustain oxidative metabolism. Secondly,
studies relating to memory performance in chicks (Baker and
Edwards, 2007; Gibbs and Hertz, 2008) and rats (Newman et al.,
2011) demonstrate the importance of lactate transfer for memory
consolidation. Lastly, in vitro rat hippocampal slices prove to be
quite efficient at metabolizing lactate (Schurr et al., 1988, 1997;
Brooks, 2007). For a more complete presentation of the evidence
supporting this hypothesis, readers are directed to the following
reviews (Magistretti and Pellerin, 1996; Pellerin et al., 1998, 2007;
Schurr et al., 1999; Schurr, 2006; Pellerin, 2008; Bouzier-Sore
and Pellerin, 2013). Additionally, for a review of the similarities
between the muscular lactate shuttle and the cerebral ANLS
hypothesis, see Brooks (2002, 2009) and Gladden (2004).
A competing hypothesis, the neuron-to-astrocyte lactate
shuttle (NALS) (Mangia et al., 2009), is based on a number of
arguments that center on the different characteristics of GLUT1,
the glucose transporter found on the epithelial cells of blood
vessels and on astrocytes, and GLUT3, the transporter found
mainly on the neuropil of neurons (Chih et al., 2001; Chih and
Roberts, 2003; Mangia et al., 2009, 2011; Massucci et al., 2013).
GLUT1 has a high affinity for glucose (Heyes, 2010) and is also
capable of transporting other hexose at a much-reduced rate
(Gould et al., 1991). GLUT1 appears to be more prevalent on
the luminal membrane of the vascular epithelium compared to
the abluminal side (Farrell and Pardridge, 1991; Simpson et al.,
2001; Cornford and Hyman, 2005; Kubo et al., 2015), though
the exact ratio and distribution is debated (Farrell and Pardridge,
1991; Akiyoshi et al., 1999). This asymmetrical distribution of
GLUT1 and the presence of hexokinase within the cells suggest
that glucose is mostly transferred unidirectionally from blood to
brain even though, given greater brain glucose concentrations,
glucose could be transported from brain to blood. Based on its
transport kinetics, the ability the transporter GLUT3 to transfer
glucose is thought to be greater than GLUT1, making glucose
entry into neurons more efficient (Simpson et al., 2007, 2008).
However, the necessity for glucose to diffuse through endothelial
cells, pericytes, astrocytes as well as the extracellular space can
limit neuronal access suggesting that high affinity transporters
may be essential to utilizing any residual glucose found in the
extracellular space following its transport through the numerous
membranes.
Similar to glucose, lactate transport between blood and
brain appears to be bidirectional and favors the use of the
monocarboxylate transporter MCT1. MCT1 transport of lactate
begins with a proton binding and ends with the dissociation
of the proton and the lactate ion on the opposite side of the
membrane (Halestrap and Price, 1999). MCT1 is also capable of
transporting other naturally-occurring monocarboxylates, such
as pyruvate, lactate, acetoacetate, and ß-hydroxybutyrate. The
transport of these other monocarboxylates, however, occurs at
a lower rate (Halestrap and Price, 1999; Juel and Halestrap,
1999; Halestrap andWilson, 2012). In contrast to GLUT1, MCT1
appears to be equally distributed between the luminal and the
abluminal membrane of epithelial cells (Leino et al., 1999; Kubo
et al., 2015).
Beyond examining the impact of systemically administered
nutrients on brain extracellular lactate and glucose, we wanted
to revisit the mechanisms involved in the memory-facilitating
effects of sugars (Gold, 1995; Messier, 2004). Glucose has
been shown to improve memory in rats, mice, pigeons, and
humans (Messier and Destrade, 1988; Parsons and Gold,
1992; Messier et al., 1998, 1999; Parkes and White, 2000)
while fructose effect has been demonstrated in rats (Messier
and White, 1987; Rodriguez et al., 1994). Both systemic and
intracerebral injections of glucose improvememory performance
(Messier and White, 1987; McNay et al., 2000). Additionally,
intra-hippocampal injections of lactate are also capable of
improving memory. In contrast, the intra-hippocampal injection
of the MCT2 (the predominantly neuronal monocarboxylate
transporter) blocker alpha-cyano-4-hydroxycinnamate (4-CIN)
impairs memory performance (Newman et al., 2011), hinting
toward an important role of lactate transport in memory. As
a first step, we examined the effects of the systemic injection
of alternative fuels on systemic and extracellular glucose and
lactate fluctuations in order to better understand the mechanisms
underlying brain energetics.
MATERIALS AND METHODS
Animals
Sixty one, 15–20 week old, male CD1 mice (Charles River
Canada, St-Constant, Québec, Canada) were individually housed
and maintained on a reverse 12-h night/day cycle with light on
at 7 p.m. Mice had ad libitum access to standard chow (Teklad
Global 18% Protein 2018, Teklad Lab Animal Diets, Envigo,
Mississauga, Canada) and water, unless otherwise specified. All
testing was conducted during the night phase of the cycle with
the use of dim red lighting. All procedures in this study adhere
to guidelines of the Canadian Council on Animal Care and were
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approved by the Animal Care Committee of the University of
Ottawa.
Surgical Procedure
Pre-surgical treatment included a 0.05 mg/kg subcutaneous (s.c.)
injection of buprenorphine hydrochloride (Reckitt Benckiser
Healthcare, Hull, North Humberside, UK) as well as 1 ml of 0.9%
saline (Hospira, Montreal, Canada).
Immediately prior to surgery, mice were anesthetised using 4–
5% isoflurane (Fresenius Kabi Canada Ltd., Richmond Hill, ON)
then secured in a stereotaxic frame (David Kopf Instruments,
Tujunga, CA, USA). Mice were maintained under anesthesia
during the surgery with 1–2.5% isoflurane and kept warm with a
heated pad (TP650, Gaymar Industries, Orchard Park, NY, USA).
Based on the stereotaxic atlas of Franklin and Paxinos (2008),
two guide cannulas (BASi cannulas Bioanalytical Systems, West
Lafayette, IN) were positioned above the left and right primary
motor cortex. The target coordinates, from Bregma, were ± 0.18
mm lateral and +1 mm anterior. The cannulas were positioned
just beneath the skulls surface so that the sensing cavity (1
mm) of the electrochemical electrode (inserted later, immediately
prior to testing) would be situated within the primary motor
cortex of the mouse (Figure 1). The guide cannulas were fixed
using a UV-polymerized compound (CG3 & CG4, Clear Cure
Goo, Southlake, TX, USA) and four 0.10′′-inch screws positioned
anterior and posterior to the two guide cannulas.
Post-surgical analgesia included application of transdermal
bupivacaine (Chiron Compounding Pharmacy Inc., Guelph, ON,
Canada) and s.c. injections of buprenorphine hydrochloride
twice daily for 3 days. Mice were given 7–8 days to recover before
testing.
Electrodes
The use and details of these commercially available electrodes
have been extensively detailed elsewhere (Wilson and Gifford,
2005; Wakabayashi and Kiyatkin, 2012; Kiyatkin et al., 2013;
Wakabayashi et al., 2015). Briefly, extracellular brain levels
of glucose and lactate were monitored using two platinum
enzyme-linked electrodes (7005-Glucose-C and 7005-Lactate-
C; Pinnacle Technology Inc., Lawrence, KS, USA). Sensors
were prepared from Pt-Ir wire of 180 um diameter, wrapped
concentrically with an AgCl reference electrode. Near the tip of
the electrode, a 1 mm section is coated with either glucose or
lactate oxidase. These enzymes oxidize the analytes of interest,
resulting in an equivalent release of hydrogen peroxide (H2O2).
H2O2 is subsequently detected and recorded as an amperometric
oxidation current by the electrode (Hu and Wilson, 1997). Data
was collected at 1 Hz, transmitted from a potentiostat to a
computer and recorded with the help of Sirenia Acquisition
Software (Pinnacle Technology Inc., Lawrence, KS, USA). In
addition to the oxidase enzymes, the metabolite sensitive surface
is also coated with a series of membranes to increase the
specificity and selectivity of the electrodes. For example, the
potential contribution of ascorbic acid is reduced with the
presence of ascorbic acid oxidase. These particular enzymes
convert the electroactive ascorbate, which has the potential to
interfere with the electrodes recordings, to non-electroactive
dehydroascorbate and water (Hu et al., 1994).
Calibration
Immediately prior to and following in vivo testing, the electrodes
were calibrated according to factory recommendations. Briefly,
the electrodes were gently placed in 100mMPBS (pH 7.4) at 23◦C
(pre-testing) or 37◦C (post-testing) and tested for metabolite
sensitivity by adding glucose (1 mM) and lactate (0.1 mM) to the
PBS solution, as well as selectivity with the use of a single ascorbic
acid (0.25 mM) addition.
Pre-calibration curves demonstrated high sensitivity with
incremental linear increases for both glucose (average sensitivity
3.32 nA/1 mM) and lactate (average sensitivity 3.40 nA/0.1 mM)
electrodes at 23◦C. Both glucose and lactate electrodes also
exhibited high levels of selectivity by demonstrating minimal
sensitivity to ascorbic acid (average sensitivity 0.18 nA/ 0.25
mM and 0.75 nA/0.25 mM, respectively). The post-calibration
curves, obtained at 37◦C, demonstrated similar results with linear
increases for both glucose (average sensitivity 5.14 nA/1 mM)
and lactate (average sensitivity 4.70 nA/ 0.1 mM) electrodes. Post
calibration curves for ascorbic acid suggested a certain level of
wear on the electrodes, most likely due to the insertion and
removal process of these sensitive testing instruments (average
sensitivity 0.79 nA/0.1 mM and 4.21 nA/0.1 mM for glucose and
lactate, respectively).
Brain Extracellular Testing Procedure
Following electrode calibration, mice were lightly anesthetised
with isoflurane and the electrodes were inserted into the motor
cortex through the surgically implanted guide cannulas and
attached to the pre-amplifier. Mice were tested in a custom-
made square polymethyl methacrylate-testing cage with standard
bedding (Teklad 7097 Corncob bedding, Envigo, Mississauga,
Canada) and water. A mounted camera (Pinnacle Technologies)
above the cage recorded the duration of the testing and was
synchronized with the electrode sampling.Mice had free access to
water but chow was removed 2 h prior to injection and returned
2 h post-injection.
Approximately 2 h following insertion, when the electrodes
returned stable readings, mice received a 2 g/kg intraperitoneal
(i.p.) injection of either glucose (Dextrose Anhydrous, EMD
Chemicals, Gibbstown, NJ, USA; n = 4), lactate (Lactic Acid,
Acros Organics, NJ, USA; n = 10), fructose (D-Fructose, Fisher
Scientific, Fair Lawn, NJ, USA; n = 6), pyruvate (Sodium
Pyruvate, Fisher Scientific, Fair Lawn, NJ, USA; n= 6), galactose
(Sigma Aldrich, St. Louis, MO, USA; n = 6), ß-hydroxybutyrate
(Sigma Aldrich, St. Louis, MO, USA; n = 5), or insulin at 1.2
I.U. (Novo Nordisk Canada Inc., Mississauga, ON; n= 7). Saline
(0.9%; Hospira, Montreal, Canada; n = 4) injections were used
as a control group. This particular dosage was chosen based on
previous results that demonstrated the ability of 2 g/kg of sugar to
improve memory (Messier and White, 1987). Additionally, this
dosage also corresponds to the amount of sugar these animals
readily ingest (Messier and White, 1984). Extracellular data was
collected for 2 h post-injection. When the testing was complete,
mice were immediately perfused. Animals that were used to test
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FIGURE 1 | Histology and Stereotaxic Location of Electrodes. On the right is a picture of a 14 µm mouse brain slice taken following the implantation of an
electrode in the primary motor cortex (M1). For comparison, on the left is a picture from the Franklin and Paxinos (2008) Mouse Brain Atlas used to determine
stereotaxic coordinates and confirm electrode placement in the primary motor cortex.
the effects of systemic injections on brain extracellular levels of
lactate and glucose were different than those used in subsequent
tests on blood glucose and lactate measurements.
Blood Tests
Blood samples were obtained by gently piercing the dorsal
tail vein with a 23 gauge needle (Becton, Dickinson and
Company, Franklin Lakes, NJ) and massaging the tail for blood
extraction. To avoid measuring pooled blood, the first blood
drop was wiped before collection. Plasma glucose and lactate
concentrations (mmol/L) were measured with a glucose (Accu
Chek, Aviva, Roche Diagnostics, Mannheim, Germany) or lactate
meter (StatStrip Xpress, Nova Biomedical, Innovation House,
Runcorn, Cheshire, UK). Prior to testing, mice were transferred
to the testing room within their respective testing cage for 1 h in
order to acclimate. A single glucose and lactate baseline measure
was taken at the end of the acclimatization period. Afterwards
mice received a 2 g/kg i.p. injection of either glucose (n = 4),
lactate (n = 4), fructose (n = 4), pyruvate (n = 4), galactose
(n = 4), ß-hydroxybutyrate (n = 4), or insulin at 1.2 I.U. (n =
4). Saline (0.9%; n = 4) injected mice were used as the control
group. Subsequently, glucose and lactate measures were taken at
30, 60, 90, and 120 min post-injection. This testing procedure
was replicated for another saline group under two additional
conditions in order to estimate the effect of stress. These groups
were sampled every 5, rather than 30 min with half of them
undergoing 15 min daily manipulation for 2 weeks (n= 4) while
the other half did not (n= 4).
Histology
Following testing, mice were lightly anesthetised using isoflurane
and the electrodes gently removed for post-calibration. Following
calibration, the mice received an i.p. injection of sodium
pentobarbital (65 mg/kg; MERK, Kirkland, QC, Canada) before
being transcardially perfused with a 4% paraformaldehyde/0.2%
picric acid solution (PFA). Brains were then postfixed in the same
PFA solution for 1 h at 4◦C, then transferred to 10% sucrose
overnight. The following day, the brains were frozen with CO2
and stored at −80◦C for later cryostat sectioning at 14 µm.
Electrochemical electrode placement within the primary motor
cortex was confirmed with the use of the stereotaxic atlas of
Franklin and Paxinos (2008).
Statistical Analysis
Glucose and lactate fluctuations observed in the periphery and
extracellular space following various metabolic challenges were
analyzed separately. A 2-h time frame was used because the
observed metabolites usually returned to baseline or stabilized
within this time.
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Relative Measures
All data were standardized by dividing the readings, in nA, by
their respective pre-event baseline and multiplying the result
by 100 to obtain relative percentage change from baseline. For
electrochemical electrode values, each baseline was individually
calculated with an average of 10 s before injection and every 120
consecutive measurements were averaged in order to obtain a
mean value every 2 min.
Glucose and lactate were analyzed separately with a between-
within (split-plot) mixed ANOVA (α = 0.05), and the data
obtained for each injection was compared to the saline injection
group as well as baseline. Unless otherwise stated, the data
met the respective assumptions of the analysis. If sphericity or
homogeneity was violated, a Greenhouse-Geisser correction was
applied. Due to the a priori decision and interest in differences
across groups, post-hoc pairwise comparison tests (α = 0.05)
were computed in order to compare the experimental groups to
the saline controls as well as compare the experimental groups
amongst themselves. All statistical analyses were performed using
SPSS v. 23 (IBM).
RESULTS
Table 1 present a summary of blood and brain extracellular levels
of glucose and lactate following systemic injections.
Effect of Stress on Peripheral Values of
Glucose and Lactate
It has been previously established that stress can increase
systemic levels of glucose and lactate in a variety of species
(Silbergeld, 1974; Wells et al., 1986; Nagamatsu et al., 1994; Hall
and Van Ham, 1998; Adolphs et al., 1999; Rand et al., 2002;
Gruber et al., 2010), including rodents (Barnett et al., 1960;
Abel, 1994; Vachon and Moreau, 2001; Sim et al., 2010) and
humans (Sharda et al., 1975; Munck et al., 1984; McCowen et al.,
2001). Unsurprisingly, taking tail vein blood in awake mice can
TABLE 1 | Summary of glucose and lactate trends following injections.
Glucose Lactate
Injection Brain Blood Brain Blood
Saline :(Baseline) :(Baseline) :(Baseline) :(∼200%)
Glucose :(∼180%) :(∼180%) :(Baseline) :(∼400%)
Fructose :(∼165%) :(Baseline)
:
(∼80%) :(∼400%)
Lactate :(∼175%) :(Baseline) :(Baseline) :(∼500%)
Pyruvate :(∼155%)
:
(∼80%)
:
(∼80%) :(∼550%)
ß-Hydroxybutyrate :(∼185%)
:
(∼70%)
:
(∼70%) :(∼600%)
Galactose :(Baseline) :(∼120%) :(Baseline) :(∼350%)
Insulin
:
(∼60%)
:
(∼50%)
:
(∼60%) :(∼280%)
Table 1. Illustration of the metabolite trend (glucose or lactate) in their respective
compartments (blood and extracellular space of the brain) following the systemic injection
of metabolic fuels. Arrows indicate whether the metabolite increased ( :), decreased (
:
)
or remained at baseline (:). Values depict the approximate zenith or nadir achieved
by these metabolites, in relation to their baseline (i.e., glucose decreased up to 80% its
baseline value in the blood following a pyruvate injection).
cause significant stress. Because we were testing the impact of
substances that influence blood glucose and lactate, which can
in turn have an impact on brain extracellular glucose and lactate
levels, we used a sampling procedure that would minimize the
effect of stress while still providing useful data. We tested a
number of alternatives. Figure 2 illustrates the fluctuations of
blood lactate and glucose following sampling conducted every 5
min without (2A) and with a 2-week habituation/handling period
(2B). Figure 2C presents the results using a 30-min sampling
interval. Split-plot mixed ANOVA did not reveal any significant
effect of group for either blood glucose [F(2, 9) 3,87, p = 0.061,
Observed Power = 0.545] or lactate [F(2, 9) 0,285, p = 0.759,
Observed Power= 0.083] values. However, pairwise comparisons
for glucose did indicate a significant between group difference
when comparing the 5 min sampling paradigm to the 30 min
sampling paradigm (p = 0.023) but not when comparing the
30 min sampling paradigm and the 5 min sampling paradigm
with prior habituation (p = 0.107). Therefore, sampling every
30 min produced similar values as those obtained following a
2-week habituation period. Pairwise comparisons did not reveal
statistically significant differences between the lactate levels of the
different sampling paradigms. In summary, regular manipulation
and habituation results in similar levels of physiological
stress responses to the 30-min sampling paradigm. Thus, the
following peripheral data were obtained with a 30-min sampling
paradigm.
Intraperitoneal Injection of Alternative
Fuels Increases Systemic Lactate
Figures 3A–E shows increased systemic lactate above saline
values after each of the injected metabolites, while systemic
glucose remained mostly unchanged (with the obvious exception
of the glucose injection). The insulin injection (Figure 3G)
reduced blood glucose values but did not change blood
lactate levels except for the first 30-min sample, most likely
a consequence of the i.p. injection and the related stress.
The analysis of peripheral glucose and lactate indicated a
significant effect of time [F(4, 96) 4.59, p = 0.002, η
2 =
0.160; F(2.39, 57.45) 60.26, p < 0.000, η
2 = 0.715] and injected
substance [F(7, 24) 4.10, p = 0.004, η
2 = 0.545; F(7, 24) 3.52,
p = 0.010, η2 = 0.507], respectively. Pairwise comparisons
were conducted to determine which group(s) significantly
differed from control (saline) values as well as determine the
precise times at which these values differed from both saline
and baseline levels (as indicated on Figures 3 A–G). Post-hoc
analyses demonstrated that the only injection capable of raising
systemic glucose above saline values was, unsurprisingly, the
glucose injection. Also, the injection of galactose slightly raised
blood glucose above baseline values at 30 and 90 min post-
injection. Pairwise comparisons confirmed that lactate, pyruvate,
and ß-hydroxybutyrate injections increased blood lactate levels
above saline values. The percent average blood lactate increase
following the injection of glucose (p = 0.563), fructose (p =
0.290), galactose (p = 0.449), pyruvate (p = 0.267), and ß-
hydroxybutyrate (p = 0.244) was not statistically different from
that observed after a lactate injection. However, the injection
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FIGURE 2 | Relative blood concentration of glucose and lactate
following a 0.9% i.p. injection of saline (A) at 5 min sampling interval in
naïve mice (n = 4); (B) at 5 min sampling interval in habituated mice (n = 4);
(C) and at 30 min sampling interval in naïve mice (n = 4). Values are expressed
as a percent of their baseline value (taken prior to injection) and error bars
represent the standard error of the mean.
of glucose, fructose and galactose produced smaller blood
lactate increases and the comparison with saline injection values
were only significant for glucose and fructose at the 30-min
sample.
Systemic Injection of Alternative Fuels
Increases Glucose and Decreases Lactate
in the Primary Motor Cortex Extracellular
Space
Figure 4A shows the effect of a saline injection on extracellular
glucose and lactate content in the primary motor cortex. Of note
is the initial, significant transitory rise in extracellular lactate
(30%), which returns to baseline 10–15 min post-injection. As
this rise in extracellular lactate is consistently observed in all
conditions immediately following injections, we suggest that it is
a result of restraining of themice and subsequentmotor behavior.
Indeed, injecting the mice require their restraint which results in
struggling during the injection procedure. Immediately following
the injection, mice typically engaged in enhanced grooming, and
running behavior for approximately 10 min. Although we did
not quantify motor activity during the post-injection period, the
video recordings were annotated to show bouts of running or
intense grooming. In general, the level of activity appeared higher
in the saline group and was mostly similar across experimental
groups except for mice receiving lactate, which were less active.
Also, the changes in extracellular lactate and glucose associated
with discrete motor activity were much less than the changes
associated with the systemic injections and were not found to
be a significant contributing factor in the present experiments.
Finally, this small lactate increase associated with the initial
injection occurred for all substances injected except for lactate;
following a lactate injection, the injection-associated rise is
greater (50%) and returns to baseline 30 min later. Additionally,
toward the end of the 2-h testing period, there is a small steady
decline in glucose level that is likely associated with the 4-h
fasting.
Figures 4B–G show that the systemic injection of alternative
fuels significantly increased extracellular glucose levels, beyond
what was observed following a saline injection. Extracellular
glucose but not lactate showed a significant effect of substance
injected [glucose: F(7, 40) 6.62, p < 0.000, η
2 = 0.537; lactate:
F(7, 40) 2.09, p = 0.067, η
2 = 0.268], and a significant effect of
time [glucose: F(59, 2360) 30.66, p < 0.000, η
2 = 0.434; lactate:
F(59, 2360) 44.37, p < 0.000, η
2 = 0.526], respectively. We were
interested in examining the differences between saline and each
substance as well the significance of the differences between the
baseline values and values after injections. On each panel of
Figure 4, we indicated the significance of pairwise comparison
between the values obtained after the saline injection and those
observed after each substance. The thin horizontal lines below
each graph represent significant tests for extracellular glucose
values while the thicker horizontal line indicates significant tests
for extracellular lactate values.
When the effects of alternate fuels on extracellular glucose
are examined, all substances except galactose produce a rise in
extracellular glucose. This difference between galactose and other
metabolic substrate will be addressed later in the discussion.
Among these significant effects, there are similarities and
differences in the slope of the initial increase in extracellular
glucose and the time period during which extracellular glucose
remains elevated. First, the extracellular glucose rates of rise
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FIGURE 3 | Relative blood concentration of glucose and lactate following a 2 g/kg i.p. injection of (A) glucose (n = 4); (B) fructose (n = 4); (C) lactate
(n = 4); (D) pyruvate (n = 4); (E) β–hydroxybutyrate (n = 4); (F) galactose (n = 4). (G) Relative blood concentration of glucose and lactate following a 1.2 I.U. i.p.
injection of insulin (n = 4). Values are expressed as a percent of their baseline value (taken prior to injection) and error bars represent the standard error of the mean.
* = significant difference when compared to control (saline) values (p < 0.05) & = significant difference when compared to baseline (p < 0.05).
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FIGURE 4 | Relative extracellular concentration of glucose and lactate following a (A) 0.9% i.p. injection of saline (n = 4), a 2 g/kg i.p. injection of (B) glucose
(n = 4); (C) fructose (n = 6); (D) lactate (n = 10); (E) pyruvate (n = 6); (F) β–hydroxybutyrate (n = 5); (G) galactose (n = 6), as well as (H) a 1.2 I.U. i.p. injection of
insulin (n = 7). Values are expressed as a percent of their baseline value (taken prior to injection) and error bars represent the standard error of the mean. The thin
horizontal lines below each graph represent significant tests for extracellular glucose values while the thicker horizontal line indicates significant tests for extracellular
lactate values (p ≤ 0.05). Significant tests for comparisons between saline values are indicated separately from the comparison with baseline values.
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following glucose, lactate and ß-hydroxybutyrate injections are
very similar. Also, extracellular glucose rates are almost identical
when comparing the effect of fructose and pyruvate injections.
Possibly, the rapid rise in extracellular glucose observed after
the systemic injection of glucose, lactate and ß-hydroxybutyrate
is associated with their greater ability to cross the blood brain
barrier or the ease with which they are systemically metabolized.
In contrast, the delayed rise in extracellular glucose observed
after the systemic injection of fructose, pyruvate and galactose
may reflect the slower transport or the requirement of additional
metabolic steps to transform fructose, pyruvate, and galactose
into easily transportable substrates. Finally, we observed that the
effect of the injection of lactate on extracellular glucose levels is
much more variable than what was found for other injections.
We could not identify any mediating variable for this variability
in the present results.
The effects of alternate fuels on brain extracellular lactate
present a different pattern altogether. First, the systemic injection
of fructose, pyruvate, and ß-hydroxybutyrate all led to significant
decreases in brain extracellular lactate. This decrease was absent
following the systemic injection of glucose, lactate and galactose.
We also noted that all systemic injections, including saline, briefly
increased extracellular lactate levels but this increase was greater
and more sustained after the systemic injection of lactate. We
now turn to the effect of systemic insulin on extracellular glucose
and lactate.
Systemic Insulin Decreases Glucose and
Lactate in the Primary Motor Cortex
Extracellular Space
The decrease in extracellular glucose following systemic insulin
has been described previously (McCall et al., 1986) and is thought
to be associated with the decreased blood glucose levels and
the proportionally reduced gradient-dependent transport from
blood to brain. Systemic insulin also reduced extracellular lactate
at exactly the same rate and extent, as was extracellular glucose.
The 40% decrease in extracellular lactate was greater than the one
that followed the systemic injection of fructose (20%), pyruvate
(20%), and ß-hydroxybutyrate (30%).
Comparisons of Trends between Blood and
Brain Extracellular Levels of Glucose and
Lactate Following Systemic Injections
If the brain-blood barrier transport of glucose and lactate are
solely taken into account, the brain extracellular levels of glucose
and lactate should be proportional. For glucose, previous data
has described a relation between blood and brain glucose that is
usually described as brain glucose being 20–30% of blood glucose
(Silver and Erecinska, 1994). This relation is maintained during
fasting as well following insulin injections (Dunn-Meynell et al.,
2009). In the present set of results, this relationship was observed
following glucose and insulin systemic injections. However, the
systemic injection of pyruvate and ß- hydroxybutyrate both led
to a decrease in blood glucose and a rise in brain extracellular
glucose. Conversely, the systemic injection of fructose and lactate
did not raise blood glucose levels but led to an increase in brain
glucose levels.
Finally, lactate transport is thought to be directional and
dependent, among other factors, on concentration gradient
across the blood-brain barrier (Figley, 2011). In the present
experiments, only the systemic injection of lactate slightly
increased brain extracellular lactate levels. Two other metabolic
substrates, ß-hydroxybutyrate, and pyruvate, that increased
blood lactate to similar levels as the systemic injection of lactate
were associated with decreased brain extracellular lactate levels.
Systemic injections of glucose, fructose and galactose all led to
equivalent increased blood lactate levels but glucose and galactose
did not produce lower brain extracellular lactate levels while
fructose did. Together these observations suggest that blood
and brain extracellular levels of glucose and lactate do not
follow a simple distribution based on blood brain transport and
concentration gradient between blood and brain.
In summary, the systemic injection of various metabolic
substrates in awake and freely moving mice led to variations in
brain extracellular lactate levels in the motor cortex (see Table 1
for a summary). These metabolic substrates were injected in
quantities consistent with typical food ingestion or exercise and
were not supra-physiological. Insulin injections did not impair
the animals’ movement and did not induce loss of consciousness.
Although the experimental conditions are obviously artificial, we
nonetheless devised test conditions that are relevant for normal
physiological states. Finally, the animals across groups were
comparable regarding their motor activity except the animals
in the lactate group that tended to be less active. During their
random bouts of activity, the extracellular glucose and lactate
changes observed in the motor cortex of all mice were much
smaller than that produced by the systemic injections. Also, the
motor activity was randomly distributed throughout the test
session with the exception of the period immediately following
the systemic (i.p.) injection when the animals struggled briefly
and moved about the cage after being released from the hold of
the experimenter. Within the limits of the present experimental
design, the present results provide new information on how
metabolic fuels are transferred and used by the brain and also
raise a number of questions that need to be addressed.
DISCUSSION
Methodological Considerations
Before we discuss the results of the present experiments, a
number of aspects of the techniques used and the nature of
the sampling have to be stated. First, we measured glucose and
lactate extracellular levels in the motor cortex of freely moving
mice. Although mice could move around the testing enclosure,
the amount of activity was limited to a few bouts randomly
spread out during the 2 h of observation. Second, the brain
extracellular milieu is a site of bilateral exchange between the
brain parenchyma and blood circulation. The electrochemical
electrodes that we inserted in the motor cortex measure the
content of glucose and lactate in that milieu (net flux) but
give no information as to the directional flux (influx vs. eﬄux)
of the metabolites. Thus, the brain extracellular milieu is like
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an antechamber where people go through to enter a room.
Figuratively, our measures give information on the number of
people transiting in the antechamber at any given time but
no information on whether they are going into the room or
leaving it.
We used percentage of change over baseline to present data
to allow interindividual and group comparisons. In theory, the
use of pre- and post-calibration could allow us to provide
absolute values. However, a number of limitations make this
difficult. First, pre-calibration of the electrodes provides the
values that allow the direct conversion between current recorded
and concentration of glucose or lactate. When the electrodes are
inserted into the living brain, the physical electrode damages
brain tissue and initiates the usual responses to insult, including
inflammation and microglial activation. The adaptation period
we used here (about 2 h) appears to lead to the stabilization of the
recorded current at the electrode, which likely corresponds to the
end of the acute response to tissue damage following electrode
insertion. Following that period, the electrodes appear to react to
brain activation and systemic injection rapidly and consistently.
There is a small consistent and mostly linear decline in current
over 24 h that is likely due to biofouling, the accumulation
of biological material or cells on the electrode surface. Post-
calibration, in theory, measures the electrode sensitivity at
the end of the experiment. However, it has been a challenge
to remove electrodes through the guide cannula holding the
electrode in place without any damage to the membranes so as
to provide reliable measurements across all animals.
The main concern with comparing percentage of change
over baseline measures of glucose and lactate is their respective
difference in absolute concentration in the brain. As calculated
with the use of our electrode calibration, average baseline brain
extracellular values of glucose and lactate were 1.4 ± 0.59 and
0.9± 0.56 mmol/L, respectively. Average blood values of glucose
and lactate ranged from 8 to 10 mmol and 1.7 to 3.1 mmol/L,
respectively. The observed brain extracellular glucose values fell
within the expected 20% of blood concentration; however, brain
extracellular lactate values were closer to 35–40% of blood values.
Additionally, when glucose is metabolized through the glycolytic
pathway, each molecule of glucose gives rise to two lactate
molecules. As a consequence, analysis of relative changes of these
metabolites in the brains’ extracellular space, or the periphery,
may lead to an overestimation of the absolute contribution these
metabolites to brain energetics. For example, if blood lactate rises
400%, blood lactate concentration rises from 2.5 to 10 mmol/L.
This near 400% rise in blood lactate is regularly observed in
exercise studies, reaching values close to or above 10 mmol/L
(Wasserman, 1967; Meek et al., 2009; Petrosino et al., 2016). In
contrast, if blood glucose only rises 10%, blood concentration
goes from 9 to 9.9 mmol/L. Thus, a 400% rise in lactate depicted
in a graph may give the illusion that blood lactate levels greatly
exceed that of glucose and these results interpreted as lactate
having a greater relative contribution. With these caveats in
mind, we now turn to possible hypotheses that can be used to
account for our observations. These hypotheses are presented
as possibilities and not as a conclusive interpretation of our
results.
Peripheral Increases in Lactate Mediate
Some of the Brain’s Use of Systemic
Metabolic Fuels
The primary finding culminating from this work is the
observation of an uncoupling occurring between extracellular
and blood values of our two metabolites of interest. Indeed,
we observed a robust and long lasting increase of blood
lactate following the systemic injection of glucose, fructose,
lactate, pyruvate, and ß-hydroxybutyrate that was accompanied
by maintained (ex: fructose) or even decreased (ex: ß-
hydroxybutyrate) blood glucose levels. In contrast, brain
extracellular levels of these two metabolites follow opposing
trends with glucose increasing and lactate maintaining either a
steady-state or decreasing. As such, individually, it would appear
that these metabolites are uncoupled between the periphery and
the brain.
Though thesemetabolites appear to be individually uncoupled
(e.g.,: blood lactate levels not predicting brain lactate levels),
the data suggest that they do not act independently of one
another. A possible interpretation of the observed pattern of
these metabolites and how they may influence each other
would be that these metabolic substrates (except, of course,
lactate) are first metabolized to lactate in the liver. The lactate
produced by the liver then enters the brain and used either as
a signaling molecule (Barros, 2013; Tang et al., 2014; Mosienko
et al., 2015) or for oxidative metabolism (Waagepetersen et al.,
1998a,b; Serres et al., 2003; Kasischke et al., 2004). Thus,
metabolic substrates would first be transformed into lactate
before the brain can use them. This view is supported by the
negligible rise in blood glucose following the injection of most
alternative fuels (except, of course, glucose) and the high rate
of conversion of these substrates to lactate, including glucose
(Kreisberg et al., 1970). The liver is capable of metabolizing
various substrates to lactate. Indeed, pyruvate can be easily
converted to lactate with the ubiquitous presence of LDH5 that
favors the conversion of pyruvate to lactate (Wroblewski and
Gregory, 1961; Fritz et al., 1969). Fructose can be converted
to lactate through fructokinase, aldolase B and triokinase:
enzymes that allow fructose to enter the glycolytic pathway
as well as undergo gluconeogenesis (Exton and Park, 1968;
Mayes, 1993). ß-hydroxybutyrate can be converted to aceto-
acetyl CoA and enter the TCA cycle for oxidative metabolism
(Bergman, 1971; Robinson and Williamson, 1980; Armulik et al.,
2010) or, alternatively, be converted into acetone and enter the
methylglyoxal pathway where it can ultimately be converted
to lactate (Armulik et al., 2010; Glew, 2010). Thus, fructose,
pyruvate and ß-hydroxybutyrate, after conversion to lactate, can
enter the TCA cycle for oxidative metabolism without being
first converted to glucose. Furthermore, some of these substrates
have been shown to decrease the contribution of glucose carbon
into CO2 (Rolleston and Newsholme, 1967; Ide et al., 1969)and
hepatic glucose uptake (Davis et al., 1984; Larrabee, 1995). In
addition to the liver’s ability to convert most substrates to lactate,
endothelial cells of blood vessels also exhibit a highly glycolytic
nature that commonly metabolizes glucose, or other substrates,
to lactate which hints toward favorable export of lactate to
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surrounding organs (Mann et al., 2003; De Bock et al., 2013; Eelen
et al., 2015). The injection of glucose, fructose, lactate, pyruvate,
and ß-hydroxybutyrate have been shown to raise blood lactate
(Huckabee, 1958; Kaye et al., 1958; Sahebjami and Scalettar, 1971;
Davis et al., 1984; Hallstrom et al., 1989; Pan et al., 2000; Abi-Saab
et al., 2002; Revelly et al., 2005; Kohler et al., 2007) however this
is the first demonstration and comparison of the similarity with
which they seem to affect two major metabolic fuels (i.e., glucose
and lactate).
Despite the liver’s ability to convert these substances to lactate
and lactate’s ability to cross the blood-brain barrier and act
as an alternative fuels, it is important to note that lactate, as
a signaling molecule, may also regulate pathways involved in
memory formation and (unsurprisingly) homeostatic metabolic
properties of cells and organs (Barros, 2013; Boury-Jamot et al.,
2016). In the brain, recent evidence has demonstrated presence
of the HCAR1 gene in neurons (Bergersen and Gjedde, 2012).
In adipocytes, this gene codes for a Gi-coupled lactate receptor
capable of inhibiting adenylyl cyclase (Lovatt et al., 2012).
Though the elucidation of the functional role of HCAR1 is still
lacking, the presence of such a receptor may further emphasize
the role of lactate as a signaling molecule and its role in
maintain metabolic homeostasis. Indeed, Barros (2013) states the
limitations of pure neuronal glucose use and discusses the ways
in which astrocytic lactate could be used. Of particular interest
is their discussion of “metabolic recruitment by lactate” which
illustrates how lactate could participate in maintaining metabolic
homeostasis by means other than acting as an alternative fuel.
For example, lactate could stimulate inhibitory GABAergic
neurons (Shimizu et al., 2007) and promote lateral inhibition
leading to increased metabolic availability of substrates to the
remaining active neurons. Also, as demonstrated by Rovetto
(Rovetto et al., 1975) and others (Gilbert et al., 2006; Shimizu
et al., 2007; Ruusuvuori et al., 2010), lactate could increase the
acidification of cells and therefore decrease their spontaneous
activity. Interestingly, lactate may account for the observations
that astrocytes decreased their use of glucose and glycogen in
active regions of the brain (Pellerin and Magistretti, 1994; Loaiza
et al., 2003; Porras et al., 2004, 2008; Bittner et al., 2011; Zhao
et al., 2011) while decreasing their glucose use in less active
brain regions (Sotelo-Hitschfeld et al., 2012), thus facilitating the
diffusion of glucose from areas of low activity to areas of high
activity.
In the next section, we explore three hypotheses that could
explain the metabolic uncoupling observed in our data. We
explore these options within a perspective of lactate as a
metabolic fuel. However, it is crucial to remember that this is a
limited perspective of how the brain may be adapting to these
changes in the systemic availability of metabolites. Any changes
or adaptations occurring could be the downstream consequence
of the initial rise in extracellular lactate.
Extracellular Brain Increases in Glucose:
Gluconeogenic Hypothesis
This hypothesis is based on the long-held belief that glucose is
the preferred and principal brain fuel (Lipton and Robacker,
1983; Levine et al., 1998). The blood lactate increase following
the systemic injection of glucose, fructose, lactate, pyruvate
and ß-hydroxybutyrate is consistent with previous observations.
However, explaining and understanding the increase in brain
extracellular glucose following these systemic injections requires
more thought. The hypothesis that lactate is a gluconeogenic
precursor (Struck et al., 1965; Ross et al., 1967; Kreisberg et al.,
1970; Bergman et al., 2000) and that the increase in brain
extracellular glucose results from excess peripheral lactate being
converted to glucose faces a number of objections. Although
there has been indication of increased gluconeogenesis at the
blood-brain barrier (Daneman et al., 2010), it is highly unlikely
that this conversion would occur in endothelial cells at a rate
significant enough to raise brain extracellular glucose levels by
30% as endothelial cells are highly glycolytic. Gluconeogenesis
has been shown to occur in astrocytes (Wiesinger et al., 1997),
however this would again imply that the lactate crosses the
blood-brain barrier and is converted to glucose while no brain
extracellular lactate increase is detected by the lactate biosensor.
Indeed, our present data show that brain extracellular lactate
decreases below baseline 20 to 40 min after the injection of
fructose, pyruvate and ß-hydroxybutyrate. If we interpreted these
observations using this hypothesis, it would imply that the rate
of gluconeogenesis greatly exceeds the rate of lactate entry. This
seems unlikely as astrocytes appear to favor the release of lactate
and not glucose (Dringen et al., 1993). In addition, sustaining
such a high rate of gluconeogenesis would be extremely costly as
gluconeogenesis is an energy dependent process (Katz, 1985).
Glucose Sparing Hypothesis
This hypothesis suggests that the increased brain extracellular
glucose is the result of decreased glycolysis since, as we previously
indicated, gluconeogenesis is a costly, energy-dependent process
(Katz, 1985). In this hypothesis, astrocytes take up lactate and
later shuttle it to surrounding neurons using the astrocytes’ fine
processes that ensheath synaptic sites. Similarly to the postulated
ANLS, this alternative hypothesis would suggest that increased
extracellular cerebral glucose is a consequence of increased
lactate use and shuttle to neurons, thus limiting the need for
glucose-based glycolysis and increasing lactate-based oxidative
metabolism in neurons. Consequently, favoring lactate-based
oxidative metabolism and decreasing glucose-based glycolysis
would lead to the eventual accumulation of glucose in the
brain extracellular space. In vitro work supports this notion as
lactate has been shown to decrease glucose use in neuronal and
astrocytic cell cultures (Tabernero et al., 1996; Schurr et al., 1999;
Schurr andGozal, 2011). Further evidence supporting the lactate-
shuttling capabilities of astrocytes is the presence of lactate
transporters that favor lactate-export (Mann et al., 2003; De Bock
et al., 2013; Eelen et al., 2015) as well as the differential expression
of LDHs in neurons and astrocytes. Neurons preferentially
present with higher levels of LDH1, which favor the lactate to
pyruvate reaction, while astrocytes preferentially present with
higher levels of LDH5, which favor the pyruvate to lactate
conversion (Venkov et al., 1976; Bittar et al., 1996; Laughton
et al., 2000). In other words, astrocytes can convert the glycolytic
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by-product pyruvate to lactate and export it into the extracellular
space.
However, the ability to export lactate is not sufficient to
explain the rise and subsequent decrease in extracellular glucose.
Indeed, if the brain extracellular glucose increase is the result
of lack of use, transport kinetics and concentration gradient
should counter that accumulation. However, as previously
mentioned, lactate function in the brain is not limited to its
metabolic properties but can also function as a signalingmolecule
capable of regulating pathways involved in memory formation
and (unsurprisingly) homeostatic metabolic properties of cells
and organs (Barros, 2013; Boury-Jamot et al., 2016). Enzyme
assays in other tissues, such as the liver and kidney, have
demonstrated the ability of acute and chronic lactate incubation
to inhibit hexokinase (and other important glycolytic regulating
enzymes) by regulating its association to mitochondria, thus
rendering it more susceptible to inhibition (Leite et al., 2011),
suggesting the possibility that high lactate transport could inhibit
glucose transport. Additionally, heart perfusion techniques in
rats demonstrated that one of the leading causes of decreased
glycolysis in hypoxic hearts is a decrease in pH caused by the
accumulation of lactate (Rovetto et al., 1975). Thus, large lactate
accumulations appear capable of decreasing glycolytic glucose
use in other organs. In contrast, another heart perfusion study
in the rat demonstrated the ability of lactate to increase the
translocation of GLUT1 to the plasma membrane (Medina et al.,
2002). Interestingly, this increased transporter translocation did
not lead to increased phosphorylation of glucose analogs but
rather to a decrease of their phosphorylation. These results lead
us to think that lactate may have similar effects in the mouse
brain, resulting in decreased hexokinase activity and thus glucose
use, but possibly increasing transport through increased GLUT1
externalization. In conclusion, the hypothesis that the brain
extracellular glucose rise we observed after systemic injection
of a number of metabolic substrates could be explained by the
preferential use of lactate and the subsequent accumulation of
glucose.
Opportunistic Hypothesis
A final consideration is the potential ability of the brain to
use metabolic substrates that are in highest concentration in
the blood, a capacity that may have a significant evolutionary
advantage for bioenergetics. In this hypothesis, glucose is most
commonly used as its blood concentration is usually significantly
higher than other substrates. Indeed, all of the metabolic
substances we injected systemically presumably raised their
blood concentration and could cross the blood-brain barrier
through GLUT1 or MCT1, albeit at variable rates (Gould et al.,
1991; Halestrap and Price, 1999; Juel and Halestrap, 1999;
Halestrap and Wilson, 2012). In addition, the brain possesses
the necessary enzymes to metabolize these various substances
(Venkov et al., 1976; Majumder and Eisenberg, 1977; Laughton
et al., 2000; Ning et al., 2001; Funari et al., 2007; Diggle et al.,
2010; McKenna, 2012). Finally, GLUT1 or MCT1 transporters
and the enzymes associated with the transport of these metabolic
substrates have been shown to be upregulated following chronic
exposure to a specific metabolic substance (Adelman et al., 1966;
Moore et al., 1976; Corring, 1980). Although it is not known
whether the brain is using these substrates directly in vivo, some
of the pre-requisite elements are present in the brain to allow this.
Because we did not measure the blood content of each metabolic
substance apart from glucose and lactate, it is difficult to evaluate
the merit of this hypothesis to explain the present results.
Galactose
Galactose was observed to significantly raise blood glucose and
blood lactate but to a smaller degree than glucose. The liver is
capable of metabolizing galactose using the Leloir Pathway that
converts galactose to glucose-6-phosphate, the first metabolic
product of glycolysis (Isselbacher, 1959; Cohn and Segal, 1973;
Holden et al., 2003). In our experiments, there was almost
no effect of systemic galactose on brain extracellular glucose
and lactate. Based on the facilitated transport of glucose, we
should have observed some increase in extracellular glucose
with the caveat that galactose may have decreased brain glucose
uptake by competing with glucose for its transport (Baur and
Heldt, 1977) or inhibiting its phosphorylation by modifying
hexokinase availability (Park and Johnson, 1955; Knull et al.,
1973). Similarly, according to the ANLS corollary noted above,
the modest increase in blood lactate could have led to an
increased accumulation of brain extracellular glucose—an effect
not observed in our experiments.
A likely explanation for the different systemic and
extracellular responses to this particular substrate may lie in the
rate of its metabolism. Fructose, pyruvate and β-hydroxybutyrate
are all quickly metabolized or excreted. This is illustrated by
studies evaluating blood content or carbon label excretion of
various metabolites. These studies highlight the mouse’s ability
to excrete or metabolize over 80% of the injected metabolites
within 2 h post-injection (Guggenheim and Mayer, 1952; Miller
et al., 1952; Eiger et al., 1980; Cha et al., 2008; Wang et al.,
2009). Particularly, fructose (4 g/kg) and β-hydroxybutyrate
(12 mg) are capable of returning to blood baseline levels 30
min following their respective injections (Eiger et al., 1980;
Cha et al., 2008). In contrast, within a 2 h window, one
experiment showed that mice are only capable of metabolizing
approximately 30% of injected galactose (Ning et al., 2001). In
that experiment, the cell concentration of galactose was <10%
of their blood concentration, indicating a slow uptake, likely a
consequence of the competition between glucose and galactose
transport. In addition to this slow rate of influx, it appears the
metabolic rate of galactose is even slower indicating that its
metabolism is not a function of its concentration-dependent
transport but rather its limited enzymatic activity (Baur and
Heldt, 1977). However, the galactose intermediate, galactose-1-
phosphate, has been identified in the mouse brain, but galactose
itself was not (Ning et al., 2001). These observations suggest
that either the small amount of galactose that can cross the
blood-brain barrier is quickly metabolized, or that the brain
is capable of endogenously producing galactose-1-phosphate.
Our observations that galactose produces little change in brain
extracellular glucose and lactate could be solely ascribed to its
limited rate of absorption. This conclusion has to be tempered
with our observation that blood glucose and lactate were elevated
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following galactose injection. Perhaps blood levels of glucose and
lactate have to reach a higher level to influence brain extracellular
glucose and lactate.
Insulin
The effect of systemic insulin injections is equally intriguing as it
illustrates the impact of reducing blood glucose levels with only a
small increase in blood lactate levels. The effect of insulin has to
be contrasted with the effect of pyruvate and ß-hydroxybutyrate
that both reduced blood glucose levels while increasing lactate
levels. Following the systemic injection of pyruvate and ß-
hydroxybutyrate, brain extracellular glucose levels are elevated
in the face of decreasing blood glucose levels. Following an
insulin systemic injection, there is a small transient increase
in blood lactate levels accompanied by a concurrent decrease
in blood glucose. Under these conditions, brain extracellular
lactate and glucose monotonically decrease in unison. Together
the effects of pyruvate and ß-hydroxybutyrate on blood and
brain glucose suggest that high blood lactate levels can sustain
high brain extracellular glucose levels even when blood glucose
levels are low. Conversely, low blood glucose together with
lower blood lactate levels cannot sustain high brain extracellular
glucose levels and brain extracellular lactate cannot compensate
for this decrease. In a preliminary experiment (data not shown)
we observed that increasing blood lactate, 2 h after an insulin
injection, led to an increase in brain extracellular glucose levels
up to 50% above pre-insulin baseline suggesting that blood lactate
can reverse the decrease in brain extracellular glucose levels
produced by systemic insulin injections.
CONCLUSION
We are aware that our observations, as they stand, cannot be
used to establish the relative prominence of the hypotheses
we entertained in the discussion because we did not measure
glucose or lactate utilization within the different brain metabolic
pathways nor did we measure the brain levels of most of the
systemically injected substances. However, our results provide
new and useful in vivo information obtained under physiological
conditions. The inescapable fact that the brain eventually ceases
to function in the complete absence of either glucose or oxygen
has focussed the theories of neuroenergetics toward the oxidation
of glucose as being the prime mechanism for energy acquisition
of the mammalian brain. However, the ability of the brain
to adapt to low glucose in insulin-injecting diabetes patients
(Maran et al., 2000), to low oxygen in people at high altitude
(Hochachka et al., 1996) and increased ketone body in diet
(Roy et al., 2015; Murray et al., 2016) suggests that the brain
makes use of more than one mechanism to acquire energy. These
alternate mechanisms can compensate for decreased glucose and
oxygen but can never completely replace oxygen- and glucose-
dependent metabolic activities. This limitation suggests that
some brain physiological activity is uniquely dependent on those
particular sources of energy. One possible candidate would be the
sodium/potassium pump that appears to be highly dependent, at
least in part, on the glycolytic pathway (Mercer and Dunham,
1981; Lipton and Robacker, 1983; Raffin et al., 1992; Pellerin
and Magistretti, 1996; Silver and Erecinska, 1997; Sepp et al.,
2014). Our in vivo results are consistent with the hypothesis
that alternate metabolic substrates can either be used by the
brain and/or reduce the need for glucose under physiological
conditions.
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